Search research articles
Contact Us
Filters
Showing results (521-530 of 540) with videos related to
Page
of 54
Sort By:
Nature Plants
|
March 28, 2025
Horizontally acquired CSP genes contribute to wheat adaptation and improvement
Kai Wang, Guanghui Guo, Shenglong Bai, et al.
Journal of Medicinal Chemistry
|
November 19, 2019
Discovery of a Highly Selective and Potent κ Opioid Receptor Agonist from <i>N</i>-Cyclopropylmethyl-7α-phenyl-6,14-endoethanotetrahydronorthebaines with Reduced Central Nervous System (CNS) Side Effects Navigated by the Message-Address Concept
Li Xiao, Yujun Wang, Mumei Zhang, et al.
JAMA Network Open
|
November 30, 2021
Postoperative Chemoradiotherapy With Capecitabine and Oxaliplatin vs Capecitabine for Stage II to III Rectal Cancer: A Randomized Clinical Trial
Ning Li, Yuan Zhu, Lu-Ying Liu, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 29, 2026
A TAD-informed aging-brain xQTL atlas of multi-modal and cell-type-resolved regulatory variation
Jeffrey Cifello, Ru Feng, Francis P Grenn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 6, 2025
Phase III Trial of Pirtobrutinib Versus Idelalisib/Rituximab or Bendamustine/Rituximab in Covalent Bruton Tyrosine Kinase Inhibitor-Pretreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (BRUIN CLL-321)
Jeff P Sharman, Talha Munir, Sebastian Grosicki, et al.
Chinese Medical Journal
|
July 31, 2018
Three-year Follow-up on the Safety and Effectiveness of Rituximab Plus Chemotherapy as First-Line Treatment of Diffuse Large B-Cell Lymphoma and Follicular Lymphoma in Real-World Clinical Settings in China: A Prospective, Multicenter, Noninterventional Study
Jian-Qiu Wu, Yong-Ping Song, Li-Ping Su, et al.
Journal of Hematology & Oncology
|
January 13, 2021
Efficacy and safety of geptanolimab (GB226) for relapsed or refractory peripheral T cell lymphoma: an open-label phase 2 study (Gxplore-002)
Yuankai Shi, Jianqiu Wu, Zhen Wang, et al.
Blood Advances
|
November 24, 2020
A risk score for predicting hospitalization for community-acquired pneumonia in ITP using nationally representative data
Ye-Jun Wu, Ming Hou, Hui-Xin Liu, et al.
Signal Transduction and Targeted Therapy
|
June 2, 2026
Anti-asthma drug montelukast induces autistic behaviors via disrupting neuronal retinoic acid signaling
Zi-Jian Hao, Qiong-Hui Wu, Ya-Li Li, et al.
Frontiers in Oncology
|
November 22, 2021
A Multi-Center, Real-World Study of Chidamide for Patients With Relapsed or Refractory Peripheral T-Cell Lymphomas in China
Weiping Liu, Donglu Zhao, Ting Liu, et al.
Page
of 54
Search research articles
Search
Showing results (521-530 of 540) with videos related to
Sort By:
Page
of 54
Nature Plants
|
March 28, 2025
Horizontally acquired CSP genes contribute to wheat adaptation and improvement
Kai Wang, Guanghui Guo, Shenglong Bai, et al.
Journal of Medicinal Chemistry
|
November 19, 2019
Discovery of a Highly Selective and Potent κ Opioid Receptor Agonist from <i>N</i>-Cyclopropylmethyl-7α-phenyl-6,14-endoethanotetrahydronorthebaines with Reduced Central Nervous System (CNS) Side Effects Navigated by the Message-Address Concept
Li Xiao, Yujun Wang, Mumei Zhang, et al.
JAMA Network Open
|
November 30, 2021
Postoperative Chemoradiotherapy With Capecitabine and Oxaliplatin vs Capecitabine for Stage II to III Rectal Cancer: A Randomized Clinical Trial
Ning Li, Yuan Zhu, Lu-Ying Liu, et al.
Medrxiv : the Preprint Server for Health Sciences
|
June 29, 2026
A TAD-informed aging-brain xQTL atlas of multi-modal and cell-type-resolved regulatory variation
Jeffrey Cifello, Ru Feng, Francis P Grenn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 6, 2025
Phase III Trial of Pirtobrutinib Versus Idelalisib/Rituximab or Bendamustine/Rituximab in Covalent Bruton Tyrosine Kinase Inhibitor-Pretreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (BRUIN CLL-321)
Jeff P Sharman, Talha Munir, Sebastian Grosicki, et al.
Chinese Medical Journal
|
July 31, 2018
Three-year Follow-up on the Safety and Effectiveness of Rituximab Plus Chemotherapy as First-Line Treatment of Diffuse Large B-Cell Lymphoma and Follicular Lymphoma in Real-World Clinical Settings in China: A Prospective, Multicenter, Noninterventional Study
Jian-Qiu Wu, Yong-Ping Song, Li-Ping Su, et al.
Journal of Hematology & Oncology
|
January 13, 2021
Efficacy and safety of geptanolimab (GB226) for relapsed or refractory peripheral T cell lymphoma: an open-label phase 2 study (Gxplore-002)
Yuankai Shi, Jianqiu Wu, Zhen Wang, et al.
Blood Advances
|
November 24, 2020
A risk score for predicting hospitalization for community-acquired pneumonia in ITP using nationally representative data
Ye-Jun Wu, Ming Hou, Hui-Xin Liu, et al.
Signal Transduction and Targeted Therapy
|
June 2, 2026
Anti-asthma drug montelukast induces autistic behaviors via disrupting neuronal retinoic acid signaling
Zi-Jian Hao, Qiong-Hui Wu, Ya-Li Li, et al.
Frontiers in Oncology
|
November 22, 2021
A Multi-Center, Real-World Study of Chidamide for Patients With Relapsed or Refractory Peripheral T-Cell Lymphomas in China
Weiping Liu, Donglu Zhao, Ting Liu, et al.
Page
of 54